CLINICAL_TRIALS
trial_result
· 2018-01-26
Clinical Trial Update: Vancomycin Dosage Adjustment for MRSA Infections [Phase 4]
Summary
Phase 4 clinical trial update focusing on vancomycin dosage adjustment for MRSA infections.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pinyo Rattanaumpawan | Conditions: Methicillin-Resistant Staphylococcus Aureus | Phase 4 | Status: UNKNOWN